Interpretation of "Clinical Considerations for Monkeypox in Children and Adolescents" released by the US Centers for Disease Control and Prevention.
10.7499/j.issn.1008-8830.2208118
- Author:
Kai-Hu YAO
1
Author Information
1. National Center for Children's Health/Beijing Children's Hospital, Capital Medical University/Laboratory of Dermatology, Beijing Pediatric Research Institute/National Key Discipline of Pediatrics (Capital Medical University)/Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing 100045, China.
- Publication Type:Journal Article
- Keywords:
Adolescent;
Child;
Clinical management;
Human monkeypox
- MeSH:
Animals;
United States;
Adolescent;
Child;
Humans;
Monkeypox/prevention & control*;
Epidemics;
Centers for Disease Control and Prevention, U.S.;
Health Personnel
- From:
Chinese Journal of Contemporary Pediatrics
2022;24(10):1078-1084
- CountryChina
- Language:Chinese
-
Abstract:
In order to cope with monkeypox in children and adolescents, the US Centers for Disease Control and Prevention released "Clinical Considerations for Monkeypox in Children and Adolescents", which is specially written for pediatric health workers serving children and adolescents under the age of 18 years to standardize the clinical management of children and adolescents with exposure to monkeypox (human monkeypox or animal monkeypox) or with suspected or confirmed monkeypox. This document highlights the characteristics of children and adolescents and gives some valuable suggestions to the special issues in pediatric clinical practice, and it is worth studying by pediatric health workers who are preparing for a possible epidemic of monkeypox.
